Search research articles
Contact Us
Filters
Showing results (41-50 of 138) with videos related to
Page
of 14
Sort By:
Human Genomics
|
October 5, 2018
Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea
Vasiliki Chondrou, Eleana F Stavrou, Georgios Markopoulos, et al.
Human Genomics
|
October 25, 2017
Whole transcriptome analysis of human erythropoietic cells during ontogenesis suggests a role of VEGFA gene as modulator of fetal hemoglobin and pharmacogenomic biomarker of treatment response to hydroxyurea in β-type hemoglobinopathy patients
Vasiliki Chondrou, Petros Kolovos, Argyro Sgourou, et al.
Annals of Internal Medicine
|
August 6, 2002
Outcome of pregnancy and disease course among women with aplastic anemia treated with immunosuppression
André Tichelli, Gérard Socié, Judith Marsh, et al.
Annals of Hematology
|
April 11, 2013
The incidence of myelodysplastic syndromes in Western Greece is increasing
Christina Avgerinou, Yannis Alamanos, Panagiotis Zikos, et al.
Journal of Clinical Medicine
|
January 26, 2024
Real-Life Multicenter Experience of Venetoclax in Combination with Hypomethylating Agents in Previously Untreated Adult Patients with Acute Myeloid Leukemia in Greece
Theodora Chatzilygeroudi, Ismini Darmani, Natali El Gkotmi, et al.
Clinical Epigenetics
|
June 15, 2024
Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML
Theodora Chatzilygeroudi, Vasiliki Chondrou, Ruben Boers, et al.
Acta Haematologica
|
June 26, 2026
Dapagliflozin in Patients with homozygous β-Thalassemia and Albuminuria
Konstantinos Tsiotsios, Sotirios Spyridon Vamvakas, Vasiliki Labropoulou, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 29, 2026
BRIDGE (OP-107): A Phase 2 Pharmacokinetic Study of Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Impaired Renal Function
Ludek Pour, Sosana Delimpasi, Wojciech Legiec, et al.
Leukemia Research
|
September 15, 2022
Evaluation of isatuximab in patients with soft-tissue plasmacytomas: An analysis from ICARIA-MM and IKEMA
Meral Beksac, Ivan Spicka, Roman Hajek, et al.
Frontiers in Medicine
|
March 7, 2022
High Frequency of Post-Transfusion Microchimerism Among Multi-Transfused Beta-Thalassemic Patients
Spyridon Matsagos, Evgenia Verigou, Alexandra Kourakli, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 138) with videos related to
Sort By:
Page
of 14
Human Genomics
|
October 5, 2018
Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea
Vasiliki Chondrou, Eleana F Stavrou, Georgios Markopoulos, et al.
Human Genomics
|
October 25, 2017
Whole transcriptome analysis of human erythropoietic cells during ontogenesis suggests a role of VEGFA gene as modulator of fetal hemoglobin and pharmacogenomic biomarker of treatment response to hydroxyurea in β-type hemoglobinopathy patients
Vasiliki Chondrou, Petros Kolovos, Argyro Sgourou, et al.
Annals of Internal Medicine
|
August 6, 2002
Outcome of pregnancy and disease course among women with aplastic anemia treated with immunosuppression
André Tichelli, Gérard Socié, Judith Marsh, et al.
Annals of Hematology
|
April 11, 2013
The incidence of myelodysplastic syndromes in Western Greece is increasing
Christina Avgerinou, Yannis Alamanos, Panagiotis Zikos, et al.
Journal of Clinical Medicine
|
January 26, 2024
Real-Life Multicenter Experience of Venetoclax in Combination with Hypomethylating Agents in Previously Untreated Adult Patients with Acute Myeloid Leukemia in Greece
Theodora Chatzilygeroudi, Ismini Darmani, Natali El Gkotmi, et al.
Clinical Epigenetics
|
June 15, 2024
Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML
Theodora Chatzilygeroudi, Vasiliki Chondrou, Ruben Boers, et al.
Acta Haematologica
|
June 26, 2026
Dapagliflozin in Patients with homozygous β-Thalassemia and Albuminuria
Konstantinos Tsiotsios, Sotirios Spyridon Vamvakas, Vasiliki Labropoulou, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 29, 2026
BRIDGE (OP-107): A Phase 2 Pharmacokinetic Study of Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Impaired Renal Function
Ludek Pour, Sosana Delimpasi, Wojciech Legiec, et al.
Leukemia Research
|
September 15, 2022
Evaluation of isatuximab in patients with soft-tissue plasmacytomas: An analysis from ICARIA-MM and IKEMA
Meral Beksac, Ivan Spicka, Roman Hajek, et al.
Frontiers in Medicine
|
March 7, 2022
High Frequency of Post-Transfusion Microchimerism Among Multi-Transfused Beta-Thalassemic Patients
Spyridon Matsagos, Evgenia Verigou, Alexandra Kourakli, et al.
Page
of 14